<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "http://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1" specific-use="sps-1.9" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">ijcs</journal-id>
      <journal-title-group>
        <journal-title>International Journal of Cardiovascular Sciences</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Int J Cardiovasc Sci </abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2359-4802</issn>
      <issn pub-type="epub">2359-5647</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id specific-use="scielo-v3" pub-id-type="publisher-id">J9RPRBhzPS57Bq3tBTMLBWs</article-id>
      <article-id specific-use="scielo-v2" pub-id-type="publisher-id">S2359-56472024000100201</article-id>
      <article-id pub-id-type="other">00201</article-id>
      <article-id pub-id-type="doi">10.36660/ijcs.20230060</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>ORIGINAL ARTICLE</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Garlic Extract Reverses Ischemic Heart Disease in Female Rats Exposed to Combined Oral Contraceptive Pills</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-7517-2590</contrib-id>
          <name>
            <surname>Nelson</surname>
            <given-names>Onitsha Enebrayi</given-names>
          </name>
          <role>Conception and design of the research, analysis and interpretation of the data and critical revision of the manuscript for intellectual content</role>
          <role>acquisition of data</role>
          <role>statistical analysis</role>
          <role>obtaining financing</role>
          <role>writing of the manuscript</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-6819-4070</contrib-id>
          <name>
            <surname>Simeon</surname>
            <given-names>Gborienemi George</given-names>
          </name>
          <role>Conception and design of the research, analysis and interpretation of the data and critical revision of the manuscript for intellectual content</role>
          <role>writing of the manuscript</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Borobuebi</surname>
            <given-names>Okutu Jackson</given-names>
          </name>
          <role>Conception and design of the research, analysis and interpretation of the data and critical revision of the manuscript for intellectual content</role>
          <role>writing of the manuscript</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wankasi</surname>
            <given-names>Mie-Ebi Martin</given-names>
          </name>
          <role>Conception and design of the research</role>
          <role>analysis and interpretation of the data and critical revision of the manuscript for intellectual content</role>
          <role>statistical analysis</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0001-5036-0862</contrib-id>
          <name>
            <surname>Chukwuma</surname>
            <given-names>Ezeiruaku Ferdinand</given-names>
          </name>
          <role>Conception and design of the research, analysis and interpretation of the data and critical revision of the manuscript for intellectual content</role>
          <role>statistical analysis</role>
          <role>obtaining financing</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <institution content-type="orgname">Niger Delta University</institution>
        <addr-line>
          <named-content content-type="city">Amassoma</named-content>
          <named-content content-type="state">Bayelsa</named-content>
        </addr-line>
        <country country="NG">Nigeria</country>
        <institution content-type="original">Niger Delta University, Amassoma, Bayelsa &#8211; Nigeria</institution>
      </aff>
      <author-notes>
        <corresp id="c01"><bold>Mailing Address: Onitsha Enebrayi Nelson.</bold> Niger Delta University, Medical Laboratory Science, College Of Health Science. Postal code: 560001. Amassoma, Bayelsa &#8211; Nigeria. E-mail: <email>brayi4life@gmail.com</email> </corresp>
        <fn fn-type="conflict">
          <p>Potential Conflict of Interest</p>
          <p>No potential conflict of interest relevant to this article was reported.</p>
        </fn>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic">
        <day>22</day>
        <month>01</month>
        <year>2024</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <year>2024</year>
      </pub-date>
      <volume>37</volume>
      <elocation-id>e20230060</elocation-id>
      <history>
        <date date-type="received">
          <day>3</day>
          <month>05</month>
          <year>2023</year>
        </date>
        <date date-type="rev-recd">
          <day>14</day>
          <month>09</month>
          <year>2023</year>
        </date>
        <date date-type="accepted">
          <day>11</day>
          <month>10</month>
          <year>2023</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
          <license-p> This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </license-p>
        </license>
      </permissions>
      <abstract abstract-type="graphical">
        <p>
          <fig id="f01">
            <label>Central Illustration</label>
            <caption>
              <title>Garlic Extract Reverses Ischemic Heart Disease in Female Rats Exposed to Combined Oral Contraceptive Pills</title>
              <p>
                <italic>Effect of aqueous garlic extract on ischemic heart disease induced by combined oral contraceptive pills in female rats COC: combined oral contraceptive.</italic>
              </p>
            </caption>
            <alternatives>
              <graphic xlink:href="https://minio.scielo.br/documentstore/2359-5647/J9RPRBhzPS57Bq3tBTMLBWs/39902dd233416d47c15422c2060699cabc84244d.tif"/>
              <graphic xlink:href="https://minio.scielo.br/documentstore/2359-5647/J9RPRBhzPS57Bq3tBTMLBWs/e8855b87d72e7ce950febc5f74aa1f71fcec5d6c.png" specific-use="scielo-web"/>
              <graphic xlink:href="https://minio.scielo.br/documentstore/2359-5647/J9RPRBhzPS57Bq3tBTMLBWs/095e412d1793da991c526e9c9705b0051918206e.jpg" specific-use="scielo-web" content-type="scielo-267x140"/>
            </alternatives>
          </fig>
        </p>
      </abstract>
      <abstract>
        <title>Abstract</title>
        <sec>
          <title>Background</title>
          <p> Garlic is an herbal medicinal plant with several pharmacological properties used for the management of various ailments. However, its potential in the reversal of ischemic heart disease induced by combined oral contraceptive pills is not well reported.</p>
        </sec>
        <sec>
          <title>Objective</title>
          <p> This study investigated the cardioprotective potential of aqueous garlic extract against cardiotoxicity induced by oral contraceptive pills.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p> Forty-six rats were used for this study. Six were used to determine the lethal dose (LD<sub>50</sub>), and 40 rats were divided randomly into 5 groups of 8 rats each. Group A received feed and distilled water. Group B received 0.6 mg/kg of oral contraceptive pills. Group C received 500 mg/kg of garlic extract. Group D received 0.6 mg/kg of oral contraceptive pills + 500 mg/kg garlic extract. Group E received 0.6 mg/kg of oral contraceptive pills + 700 mg/kg garlic extract. The animals were sacrificed, and blood and tissue samples were collected for biochemical and histological analysis. Statistical analysis was done using SPSS, and p values &lt; 0.05 were considered significant.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p> The acute toxicity dose of combined oral contraceptive pills was 1.5 mg/kg for albino rats. Combined oral contraceptive pills induced ischemic necrosis as revealed by the photomicrographs, in addition to elevation of serum cardiac troponin-1, lactate dehydrogenase, creatine kinase, and malondialdehyde levels. Treatment with garlic extract demonstrated significant reduction in cardiac troponin-1 (p = 0.000), lactate dehydrogenase (p = 0.002), creatine kinase (p = 0.001), and malondialdehyde (p = 0.001) levels, as well as restoration of the cardiac cytoarchitecture changes caused by the combined oral contraceptive pills.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p> This study has demonstrated that aqueous garlic juice can reverse ischemic heart disease, lessen cytoarchitectural alterations of the heart caused by combined oral contraceptive pills, and thus ameliorate cardiac dysfunction.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Contraceptive Agents</kwd>
        <kwd>Rats</kwd>
        <kwd>Garlic</kwd>
        <kwd>Myocardial Ischemia</kwd>
      </kwd-group>
      <counts>
        <fig-count count="6"/>
        <table-count count="2"/>
        <equation-count count="1"/>
        <ref-count count="48"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Oral contraceptives are birth control pills used by women to prevent unintended pregnancy.<sup><xref ref-type="bibr" rid="B1">1</xref></sup> They are one of the most widely used means of contraception globally, taken by over 150 million women.<sup><xref ref-type="bibr" rid="B2">2</xref></sup> They contain synthetic steroid hormones such as estrogen and progesterone that act on the hypothalamus-pituitary-gonadal axis of the female reproductive system, suppressing luteinizing hormone and follicle stimulating hormone, thus preventing ovulation.<sup><xref ref-type="bibr" rid="B3">3</xref></sup> They also alter the uterine lining to limit fetal development and increase cervical mucus secretions to inhibit sperm penetration into the cervix.<sup><xref ref-type="bibr" rid="B4">4</xref></sup>Oral contraceptive pills come in two forms: combined oral contraceptive pills, which consist of progesterone and estrogen, and progestin-only pills, which contain only progesterone.<sup><xref ref-type="bibr" rid="B5">5</xref></sup> These hormones have diverse adverse effects on tissues and organs of the body system. Estrogen induces decreased venous blood flow, arterial endothelial proliferation, and decreased plasma level of antithrombin III; it also increases blood coagulability due to changes in platelet functions and the fibrinolytic system,<sup><xref ref-type="bibr" rid="B6">6</xref></sup> while progesterone may cause decreased glucose tolerance, lower high-density lipoprotein levels, and increased levels of low-density lipoprotein, platelet aggregation, and coronary arterial spasm.<sup><xref ref-type="bibr" rid="B7">7</xref></sup> Prolonged consumption of combined oral contraceptive pills has been reported to be connected to a number of metabolic diseases, including cardiovascular diseases, such as venous thromboembolism, stroke, atherosclerosis, myocardial infraction, hypertension, bone diseases, breast cancer, endometrial cancer, and ovarian cancer.<sup><xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref></sup></p>
      <p>Ischemic heart disease is a condition in which there is an insufficient supply of blood and oxygen to the myocardium.<sup><xref ref-type="bibr" rid="B9">9</xref></sup> It is a disease in which the blood perfusion to the heart is hindered by atheroma, thrombosis, or spasm of coronary arteries, which may decrease the oxygenated blood supply to myocardium, subsequently leading to oxygen demand and myocardial ischemia, which consequently lead to cardiac muscle cell necrosis in a prolonged state.<sup><xref ref-type="bibr" rid="B6">6</xref></sup> Ischemic heart disease is the most frequent, chronic, life-threatening disease and the main cause of death in both men and women around the world.<sup><xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref></sup> Family history,<sup><xref ref-type="bibr" rid="B12">12</xref></sup> prolonged stress and other psychiatric disorders,<sup><xref ref-type="bibr" rid="B13">13</xref></sup> smoking,<sup><xref ref-type="bibr" rid="B14">14</xref></sup> obesity,<sup><xref ref-type="bibr" rid="B15">15</xref></sup> dyslipidemia,<sup><xref ref-type="bibr" rid="B16">16</xref></sup> hypertension, diabetes, and infections with certain microorganisms contribute to the development of ischemic heart disease.<sup><xref ref-type="bibr" rid="B17">17</xref></sup> Despite tremendous advancements in lifestyle modifications and pharmacological interventions of well-established risk factors over the past decades, ischemic heart disease and stroke continue to be the leading cause of mortality in advanced countries.<sup><xref ref-type="bibr" rid="B18">18</xref></sup> It is crucial to continue using preventive strategies, especially for primary prevention. Thus, society is concentrating on creating safe, accessible, and inexpensive methods for preventing diseases connected to atherosclerosis.</p>
      <p>Several plants species possess many pharmaceutical properties due to their phytoconstituents (glycosides, alkaloids, saponins, steroids, flavonoids, tannins, and terpenoids) that are useful for the formulation of new drugs in contemporary society.<sup><xref ref-type="bibr" rid="B19">19</xref></sup> Garlic (<italic>Allium sativum</italic>) is reported to be one of these herbal medicinal plants. Garlic and its derivatives have been reported to have both therapeutic and nutritional benefits since ancient times, with varying biological effectiveness.<sup><xref ref-type="bibr" rid="B20">20</xref></sup> It is used as a therapeutic agent for several metabolic diseases, such as hyperlipidemia, atherosclerosis, arrhythmia, diabetes, thrombosis, and hypertension.<sup><xref ref-type="bibr" rid="B19">19</xref></sup> According to recent scientific investigations that followed the principles of contemporary medical systems, garlic has anti-microbial, anti-thrombotic, anti-diabetic, anti-hypertensive, anti-cancer, and immunomodulatory effects.<sup><xref ref-type="bibr" rid="B21">21</xref></sup> Regarding the fact that different garlic preparations have different pharmaceutical potentials, this study investigated the ameliorative effect of aqueous garlic extract on ischemic heart disease induced by combined oral contraceptive pills in female Wistar rats.</p>
    </sec>
    <sec sec-type="materials|methods">
      <title>Materials and methods</title>
      <sec>
        <title>Study design</title>
        <p>This research utilized a randomized subject control experimental design with observational study. The researcher used a convenience sampling technique. The study was conducted in accordance with the Declaration of Helsinki and approved by the Research and Ethical Committee of College of Health Sciences, Niger Delta University. Animal handling was carried out according to Good Laboratory Practice (GLP) and in accordance with the National Institute of Health Guide for Care and Use of Laboratory Animals.<sup><xref ref-type="bibr" rid="B22">22</xref></sup></p>
      </sec>
      <sec>
        <title>Experimental animal care</title>
        <p>For this investigation, 46 apparently healthy female rats <italic>(Rattus norvegicus)</italic> weighing between 120 and 210 g were used. The animals were separated into 5 groups of 8 animals per group based on body weight and housed in cages made of metal nesting under standard conditions with temperature range of 25 to 30 &#176;C and relative humidity. They were fed with growers&#8217; mash and distilled water, with 12-hour light and dark cycles. The beddings of the cages were changed, and the cages were cleaned daily with disinfectant. Groups A (negative control) received 2 ml/kg water and normal feed. Groups B (positive control), D, and E received 0.6 mg/kg body weight of combined oral contraceptive pills only once daily in 5-day cycles (4 days of treatment with a 1-day break) for 48 days. Group C received only 500 mg/kg body weight aqueous extract of <italic>Allium sativum</italic> once daily for 48 days. Groups D and E were post-treated (48 days after exposure to combined oral contraceptive pills) with 500 mg/kg and 700 mg/kg body weight of aqueous extracts of <italic>Allium sativum</italic> for 4 weeks, respectively. The rats were allowed to acclimatize for 2 weeks before the commencement of the experiment. Out of the 46 rats, 6 were used to determine the lethal dose (LD<sub>50</sub>) of combined oral contraceptive pills.</p>
      </sec>
      <sec>
        <title>Preparation of combined oral contraceptive pills</title>
        <p>A Levofem&#174; tablet, which is a brand of combined oral contraceptive pill made up of 0.03 mg ethinyl estradiol and 0.3 mg levonorgestrel, manufactured by PT Harsen, Jakarta Timur-13750 (Indonesia) and imported and distributed by Deep K. Tyagi Foundation Nigeria was used for the study. The drugs were purchased from Danson Pharmacy Store Opolo, Yenagoa, Bayelsa State, Nigeria. The concentration of the combined oral contraceptive pills used was adopted in accordance with the method described by Toryila et al. <sup><xref ref-type="bibr" rid="B23">23</xref></sup> The package contains 28 pills; each white tablet contains 0.03 mg ethinylestradiol and 0.3 mg levonorgestrel, and each brown tablet contains 75 mg ferrous fumarate. Twenty-one white tablets of the drug were dissolved in 100 ml of distilled water. The drug was administered daily by oral gavage syringe. A concentration of 0.6 mg/kg body weight was administered daily in 5-day cycles (4 days of treatment with a 1-day break) for 48 days. The dose and volume of the drug administered was calculated using the following formula:</p>
        <disp-formula id="e1">
          <mml:math>
            <mml:mtext> Concentration of drug </mml:mtext>
            <mml:mo>(</mml:mo>
            <mml:mrow>
              <mml:mi>m</mml:mi>
              <mml:mi>g</mml:mi>
            </mml:mrow>
            <mml:mrow>
              <mml:mo>/</mml:mo>
            </mml:mrow>
            <mml:mrow>
              <mml:mi>m</mml:mi>
              <mml:mi>l</mml:mi>
            </mml:mrow>
            <mml:mo>)</mml:mo>
            <mml:mo>=</mml:mo>
            <mml:mfrac>
              <mml:mrow>
                <mml:mtext> Weight of rat </mml:mtext>
                <mml:mo>(</mml:mo>
                <mml:mrow>
                  <mml:mi>k</mml:mi>
                  <mml:mi>g</mml:mi>
                </mml:mrow>
                <mml:mo>)</mml:mo>
              </mml:mrow>
              <mml:mrow>
                <mml:mtext> Volume </mml:mtext>
                <mml:mo>(</mml:mo>
                <mml:mrow>
                  <mml:mi>m</mml:mi>
                  <mml:mi>l</mml:mi>
                </mml:mrow>
                <mml:mo>)</mml:mo>
              </mml:mrow>
            </mml:mfrac>
            <mml:mo>&#215;</mml:mo>
            <mml:mtext> Dose rate </mml:mtext>
            <mml:mo>(</mml:mo>
            <mml:mrow>
              <mml:mi>m</mml:mi>
              <mml:mi>g</mml:mi>
            </mml:mrow>
            <mml:mrow>
              <mml:mo>/</mml:mo>
            </mml:mrow>
            <mml:mrow>
              <mml:mi>k</mml:mi>
              <mml:mi>g</mml:mi>
            </mml:mrow>
            <mml:mo>)</mml:mo>
          </mml:math>
        </disp-formula>
      </sec>
      <sec>
        <title>Preparation of garlic aqueous extract</title>
        <p>Garlic bulbs were bought from a local market at Swali in Yenagoa, Bayelsa State, Nigeria. The plant bulbs were taken to the Department of Biological Sciences, Niger Delta University, Amassoma Nigeria, where they were identified by a taxonomist. The garlic aqueous extract was prepared according to the method described by Ghiasi.<sup><xref ref-type="bibr" rid="B24">24</xref></sup> Thirty grams of garlic were crushed and dispensed to 100 ml distilled water in a conical flask. The juice was obtained using a fruit juice extracting machine. The resultant homogenized mixture was then filtered 3 times with a cheese cloth and centrifuged for 10 minutes at 2000 rpm. The clear supernatant was collected in dark bottles and stored in a refrigerator at 2 to 8 &#176;C until it was used. Based on weight of the starting material (30 g per 100 ml), the concentration of prepared garlic was considered to be 300 mg/ml. The animals were treated with garlic aqueous extract (1 ml per 100 g body weight) once daily via gavage for 48 days.</p>
      </sec>
      <sec>
        <title>Drug and garlic extract administration</title>
        <p>The drug was administered once daily via oral route in a 5-day cycles (4 days of treatment with a 1-day break) using a metal cannula attached to 2.0 ml syringe, for a period of 48 days. Groups B, D, and E were exposed to 0.6 mg/kg body weight except the control group, while group C was administered with 500 mg/kg body weight of aqueous extract of garlic. Groups D and E were post-treated (after 48 days) with 500 mg/kg and 700 mg/kg body weight of aqueous extract of garlic for 4 weeks, respectively.</p>
      </sec>
      <sec>
        <title>Acute toxicity study of combined oral contraceptive pills</title>
        <p>The up-and-down method of acute toxicity studies was adopted to determine the LD<sub>50</sub> of the combined oral contraceptive pills. A total of 6 female albino rats were used (1 rat per dosage). The rats were administered with 0.4 mg/kg, 0.6 mg/kg, 0.8 mg/kg, 1.0 mg/kg, 1.2 mg/kg, and 1.5 mg/kg, one at a time. The first dosage administered was 0.4 mg/kg, and it was steadily increased by 0.2 mg/kg after 2 days if each rat survived the initial dosage. Signs of toxicity were observed continuously for the first 2 hours after treatment in all rats, then frequently for 4 hours, and thereafter for a period of 48 hours. The surviving animals were monitored for delayed death for a period 7 days, and they were observed for physical signs of toxicity such as dullness, listlessness, tremor, deep breathing, decreased respiratory rate, and death.<sup><xref ref-type="bibr" rid="B25">25</xref></sup></p>
      </sec>
      <sec>
        <title>Collection of specimens for biological and histological analysis</title>
        <p>After the required weeks of experimentation, the rats were anesthetized with chloroform and sacrificed. Blood samples were collected via cardiac puncture with syringe and dispensed into ethylene diamine tetra-acetic acid and plain sample containers for biochemical analysis. Thereafter, the rats were excised to collect heart tissues, which were fixed in 10% formal saline for histological investigations.</p>
      </sec>
      <sec>
        <title>Assessment of biochemical parameters</title>
        <p>Serum creatine kinase myocardial band (MB) was estimated by kinetic ultra-violet (UV) method according to International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) as reported by Young<sup><xref ref-type="bibr" rid="B26">26</xref></sup>with modification. Serum lactate dehydrogenase was estimated by kinetic UV method according to IFCC as reported by Cervellin et al.,<sup><xref ref-type="bibr" rid="B27">27</xref></sup> with modification. The enzyme lactate dehydrogenase catalyzes the reduction of pyruvate and NADH to form NAD . The rate of oxidation of NADH to NAD is measured as a decrease in absorbance which is proportional to the lactate dehydrogenase activity in the sample. Serum cardiac troponin was estimated using enzyme immunosorbent assay (ELISA) as reported by Babuin and Jaffe<sup><xref ref-type="bibr" rid="B28">28</xref></sup> with modification.</p>
      </sec>
      <sec>
        <title>Histopathological investigation</title>
        <p>The excised heart specimens from each rat were cut into slabs of about 6 mm<sup><xref ref-type="bibr" rid="B3">3</xref></sup> in size and fixed immediately in 10% formal saline. A Histokinette automatic tissue processor- (LEICA TP 1020) was used for tissue processing, and all tissues were embedded in paraffin wax in a tissue embedder (LEICA EG 1160). The tissue blocks were sectioned in a rotary microtome (Heitz 150 Rotary Microtome) at 5 microns. The slides were stained with hematoxylin and eosin using the method described by Ochei and Kolhatkar<sup><xref ref-type="bibr" rid="B29">29</xref></sup> for general tissue architecture. The stained slides were examined under a high-resolution microscope (Olympus BX60MF, Japan), and photomicrographs were taken at a magnification of &#215; 400.</p>
      </sec>
      <sec>
        <title>Statistical analysis</title>
        <p>For analysis of the data, Statistical Software for Social Sciences (SPSS), version 23.0 was used. One-sample Kolmogorov-Smirnov test indicated that the data were normally distributed. Two-way analysis of variance (ANOVA) was used to compare the groups. The Bonferroni multiple comparison. method was used for all post-hoc analyses. Data were presented using mean &#177; standard deviation for all quantitative values. The level of significance was set at 95% confidence interval, and p &lt; 0.05 was considered significant.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>Acute toxicity study</title>
        <p><xref ref-type="table" rid="t1">Table 1</xref> shows the results of the acute toxicity study carried out. The rats were observed for signs of toxicity (behavioral changes and death) continuously for first the 2 hours after the treatment with combined oral contraceptive pills, then frequently for 4 hours, and thereafter for a period of 48 hours. The surviving animals were monitored for delayed death for a period of 7 days. We observed no signs of toxicity and mortality in the rats administered with 0.4 mg/kg, 0.6 mg/kg, 0.8 mg/kg, and 1.0 mg/kg body weight of combined oral contraceptive pills. However, behavioral changes such as dullness, listlessness, tremor, deep breathing, redness of eye, and decreased respiratory rate were observed in the rats administered with 1.2 mg/kg and 1.5 mg/kg body weight of combined oral contraceptive pills. The LD<sub>50</sub> of combined oral contraceptive pills in female rats was estimated as a cut-off value, since no mortality occurred even at values above 1.2 mg/kg body weight.</p>
        <p>
          <table-wrap id="t1">
            <label>Table 1</label>
            <caption>
              <title>&#8211; Determination of LD50 of combined oral contraceptive pills in female adult albino rats</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup width="33%">
                <col/>
                <col/>
                <col/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left">Weight (g) </th>
                  <th>Dosage (mg/kg)</th>
                  <th>Remark</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>150 g</td>
                  <td align="center">0.4 mg/kg</td>
                  <td align="center">No toxicity sign/death</td>
                </tr>
                <tr>
                  <td>180 g</td>
                  <td align="center">0.6 mg/kg</td>
                  <td align="center">No toxicity sign/death</td>
                </tr>
                <tr>
                  <td>150 g</td>
                  <td align="center">0.8 mg/kg</td>
                  <td align="center">No toxicity sign/death</td>
                </tr>
                <tr>
                  <td>180 g</td>
                  <td align="center">1.0 mg/kg</td>
                  <td align="center">No toxicity sign/death</td>
                </tr>
                <tr>
                  <td>180 g</td>
                  <td align="center">1.2 mg/kg</td>
                  <td align="center">Dullness, listlessness, tremor, deep breathing, and no death</td>
                </tr>
                <tr>
                  <td>150 g </td>
                  <td align="center">1.5 mg/kg</td>
                  <td align="center">Dullness, listlessness, tremor, deep breathing, and no death</td>
                </tr>
                <tr>
                  <td> </td>
                  <td> </td>
                  <td align="center">respiratory rate, reduced response to stimuli, lachrymation, redness of eye.</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
        </p>
      </sec>
      <sec>
        <title>Effects of aqueous garlic extract on cardiac biomarkers and lipid peroxidation activities in female rats administered with combined oral contraceptive pills</title>
        <p><xref ref-type="table" rid="t2">Table 2</xref> shows the effect of aqueous garlic extract on some cardiac biomarkers and malondialdehyde in female Rattus norvegicus administered combined oral contraceptive pills. Serum troponin-1 (p = 0.000), lactate dehydrogenase (p = 0.0024), and creatine kinase MB (p = 0.001) levels were significantly elevated in the rats treated with only combined oral contraceptive (group B) when compared with the control (group A). Lipid peroxidation product malondialdehyde levels were significantly (p = 0.001) increased in the rats treated with only combined oral contraceptive (group B) when compared with the control (group A). However, there was a significant (p = 0.001) drastic reduction in the serum level of serum troponin-1, lactate dehydrogenase, and creatine kinase MB and malondialdehyde following treatment with 500 mg/kg and 700 mg/kg body weight of <italic>Allium sativum</italic> (groups D and E). This reduction was more pronounced in the rats treated with 700 mg/kg body weight of the garlic juice.</p>
        <p>
          <table-wrap id="t2">
            <label>Table 2</label>
            <caption>
              <title>&#8211; Effect of combined oral contraceptive pills and aqueous garlic extract on some cardiac biomarkers and malondialdehyde of female albino rats</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup width="20%">
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
              </colgroup>
              <thead>
                <tr>
                  <th rowspan="2">Treatments</th>
                  <th>cTn-1</th>
                  <th>LDH</th>
                  <th>CK-MB</th>
                  <th>MDA</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="center">
                    <bold>(ng/L)</bold>
                  </td>
                  <td align="center">
                    <bold>(IU/L)</bold>
                  </td>
                  <td align="center">
                    <bold>(IU/L)</bold>
                  </td>
                  <td align="center">
                    <bold>(nmol/L)</bold>
                  </td>
                </tr>
                <tr>
                  <td align="center">GRP A</td>
                  <td align="center">0.11 &#177; 0.02</td>
                  <td align="center">48.88 &#177; 11.53</td>
                  <td align="center">10.00 &#177; 1.46</td>
                  <td align="center">1.20 &#177; 0.24</td>
                </tr>
                <tr>
                  <td align="center">GRP B</td>
                  <td align="center">0.31 &#177; 0.03</td>
                  <td align="center">69.36 &#177; 10.06</td>
                  <td align="center">13.50&#177; 1.06</td>
                  <td align="center">2.46&#177;0.66</td>
                </tr>
                <tr>
                  <td align="center">GRP C</td>
                  <td align="center">0.10 &#177; 0.03</td>
                  <td align="center">47.32 &#177; 4.77</td>
                  <td align="center">10.10 &#177; 0.96</td>
                  <td align="center">1.06 &#177; 0.09</td>
                </tr>
                <tr>
                  <td align="center">GRP D</td>
                  <td align="center">1.15 &#177; 0.04</td>
                  <td align="center">51.04 &#177; 7.44</td>
                  <td align="center">9.20 &#177; 1.15</td>
                  <td align="center">1.71&#177;0.35</td>
                </tr>
                <tr>
                  <td align="center"><bold><italic>G</italic></bold>RP E</td>
                  <td align="center">0.09 &#177; 0.02</td>
                  <td align="center">44.49 &#177; 5.55</td>
                  <td align="center">10.30 &#177; 1.82</td>
                  <td align="center">1.40 &#177;0.16</td>
                </tr>
                <tr>
                  <td align="center">P value</td>
                  <td align="center">0.000*</td>
                  <td align="center">0.002*</td>
                  <td align="center">0.001*</td>
                  <td align="center">0.001*</td>
                </tr>
                <tr>
                  <td align="center">F value</td>
                  <td align="center">21.85</td>
                  <td align="center">0.58</td>
                  <td align="center">1.39</td>
                  <td align="center">9.24</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN1">
                <p>
                  <italic>pP values &lt; 0.05 are considered significant. CK-MB: creatine kinase MB; cTn1: cardiac troponin-1; GRP: group; LDH: lactate dehydrogenase; MDA: malondialdehyde. Group A (control) received feed and water. Group B received 0.6 mg/kg body weight of combined oral contraceptive pills. Group C received 500 mg/kg body weight of aqueous garlic extract. Group D received 0.6 mg/kg combined oral contraceptive pills + 500 mg/kg body weight of aqueous garlic extract. Group E received 0.6 mg/kg combined oral contraceptive pills + 700 mg/kg body weight of aqueous garlic extract. All post hoc testing was conducted using Bonferroni multiple comparison. *Significant difference observed, with p &lt; 0.01. Significant differences were observed for the following: cTn1 concentrations between GRP A and GRP B (p = 0.000); cTn1 concentrations between GRP D and GRP B (p = 0.000); CcTn1 concentrations between GRP E and GRP B (p = 0.000); cTn1 concentrations between GRP D and GRP E (p = 0.046); LDH concentrations between GRP A and GRP B (p = 0.014); LDH concentrations between GRP D and GRP B (p = 0.036); LDH concentrations between GRP E and GRP B (p = 0.003); CK-MB concentrations between GRP A and GRP B (p = 0.007).</italic>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </p>
      </sec>
      <sec>
        <title>Histological examination of heart tissues of female rats administered aqueous garlic extract and combined oral contraceptive pills treated</title>
        <p>As shown in <xref ref-type="fig" rid="f02">Figure 1</xref>, microscopic examination of hematoxylin and eosin-stained slides of heart tissues revealed that the transverse section of the control group (group A) showed normal histological features of the heart. The cardiocytes were normal, all suggestive of normal cardiac tissue architecture. <xref ref-type="fig" rid="f03">Figure 2</xref> shows the photomicrograph of a transverse section of the heart of an adult female rat administered with 0.6 mg/kg body weight of combined oral contraceptive pills orally for 48 days (group B). The section showed alteration in normal morphology of the heart with localized area of ischemic necrosis suggestive of obstruction in blood flow (ischemic heart disease). The substance administered is cardiotoxic at concentration and duration. <xref ref-type="fig" rid="f04">Figure 3</xref> shows the photomicrograph of a representative transverse section of an adult rat administered with 0.6 mg/kg body weight of combined oral contraceptive pills orally for 48 days and treated with 500 mg/kg body weight of aqueous garlic extract for 4 weeks after administration of oral contraceptive pills (group D). The section showed hypertrophy of the cardiocytes. The substance administered is non-toxic and shows potential ability to reverse the ischemic changes observed in group B. <xref ref-type="fig" rid="f05">Figure 4</xref> shows a photomicrograph of a representative transverse section of an adult rat administered with 0.6 mg/kg body weight of combined oral contraceptive pills orally for 48 days and treated with 700 mg/kg body weight of aqueous garlic extract for 48 days after administration of oral contraceptive pills (group E). The section showed normal histomorphology of the heart tissue. The substance administered is non-toxic and shows potential ability to reverse the ischemic changes observed in group B.</p>
        <p>
          <fig id="f02">
            <label>Figure 1</label>
            <caption>
              <title>&#8211; Photomicrograph of adult female rat heart tissue from group A (control group) stained with hematoxylin and eosin. The transverse section shows normal histological features of the heart. Slide was stained with hematoxylin and eosin. Magnification &#215; 400.</title>
            </caption>
            <graphic xlink:href="2359-5647-ijcs-37-e20230060-30060-gf01.tif"/></fig>
        </p>
        <p>
          <fig id="f03">
            <label>Figure 2</label>
            <caption>
              <title>&#8211; Photomicrograph of transverse section of heart of adult female rat administered with 0.6 mg/kg body weight of combined oral contraceptive pills orally for 48 days. The section shows alteration in normal morphology of the heart with localized area of ischemic necrosis suggestive of obstruction in blood flow (ischemic heart disease). Conclusion: The substance administered is toxic to the heart tissue at concentration and duration.</title>
            </caption>
            <graphic xlink:href="2359-5647-ijcs-37-e20230060-30060-gf02.tif"/></fig>
        </p>
        <p>
          <fig id="f04">
            <label>Figure 3</label>
            <caption>
              <title>&#8211; Photomicrograph of transverse section of an adult rat administered with 500 mg/kg body weight of aqueous garlic extracts orally for 48 days. The section shows marked cardiocyte with normal nuclear details consistent with mild atypia. Conclusion: The substance administered is non-toxic to the heart tissue at concentration and duration.</title>
            </caption>
            <graphic xlink:href="2359-5647-ijcs-37-e20230060-30060-gf03.tif"/></fig>
        </p>
        <p>
          <fig id="f05">
            <label>Figure 4</label>
            <caption>
              <title>&#8211; Photomicrograph of transverse section of an adult rat administered with 0.6 mg/kg body weight of combined oral contraceptive pills orally for 48 days and post-treated with 500 mg/kg body weight of aqueous garlic extract for 4 weeks after administration of oral contraceptive pills. The section shows hypertrophy of the cardiocyte. Conclusion: The substance administered is non-toxic and shows potential ability to reverse the ischemic changes observed in group B.</title>
            </caption>
            <graphic xlink:href="2359-5647-ijcs-37-e20230060-30060-gf04.tif"/></fig>
        </p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>The practice of utilizing medicinal herbs in the management of diseases dates back to ancient times. Garlic, notably the <italic>Allium sativum</italic> species, has long been studied for its result-oriented biological and pharmacological properties. This study demonstrated the ameliorative effect of <italic>Allium sativum</italic> on ischemic heart disease induced by combined oral contraceptive pills in female Wistar rats.</p>
      <p>In the present study, the acute toxicity test (LD<sub>50</sub>) of combined oral contraceptive pills showed no mortality in any group of the studied rats. However, the acute toxicity symptoms observed were dullness, listlessness, deep breathing, tremor, reduced response to stimuli, decreased respiration rate, lachrymation, redness of eye, and increased secretion from nose and vagina. Thus, the oral median LD<sub>50</sub> of the combined oral contraceptive pills on adult female albino rats was found to be greater than 1.2 mg/kg body weight (1200 &#181;g/kg body weight). The result corresponds with Satoskar et al.,<sup><xref ref-type="bibr" rid="B30">30</xref></sup> who reported that estrogens and progesterone may cause several unpleasant effects such as loss of appetite, vomiting, dullness, increased vaginal secretion, and breast enlargement.</p>
      <p>Combined oral contraceptive intake for a prolonged period of time is connected to increased risk of cardiovascular diseases.<sup><xref ref-type="bibr" rid="B31">31</xref></sup> Cardiac proteins which serve as biomarkers of the heart are elevated in individuals with myocardial infarction, acute myocarditis, and atherosclerosis,<sup><xref ref-type="bibr" rid="B32">32</xref></sup> and they are useful in making clinical diagnosis. A number of cardiovascular illnesses, such as myocardial infarction, acute myocarditis, and ischemic stroke, have been associated with the use of combined oral contraceptives, according to previous research.<sup><xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B33">33</xref></sup>In this study, the serum levels of troponin-1, lactate dehydrogenase, and creatine kinase MB were significantly (p &lt; 0.05) elevated in the rats treated with combined oral contraceptive pills (group B) compared with controls (group A). This increase could be due to the fact that the estrogen present in hormonal contraceptives increases cellular lipid peroxidation activities in the cell membrane, causing leakage of cardiac proteins into the extracellular fluid. It could also be attributed to elevation of many coagulation factors causing hypercoagulability,<sup><xref ref-type="bibr" rid="B34">34</xref></sup> which is seen to be the most vital determinant of atherosclerosis,<sup><xref ref-type="bibr" rid="B35">35</xref></sup> subsequently leading to myocardial infarction and ischemic stroke and causing increased cardiac troponin, lactate dehydrogenase, and creatine kinase.</p>
      <p>Oxidative stress has been shown to cause cardiovascular diseases.<sup><xref ref-type="bibr" rid="B36">36</xref></sup> Previous research has reported the generation of reactive oxygen species in combined oral contraceptive pill users. Prolonged use of contraceptive pills resulted in increased lipid peroxidation.<sup><xref ref-type="bibr" rid="B37">37</xref></sup> Malondialdehyde, a clinical indicator of oxidative stress, may be produced as a result of lipid peroxidation.<sup><xref ref-type="bibr" rid="B38">38</xref></sup> Malondialdehyde levels were significantly (p &lt; 0.05) elevated in the rats treated with combined oral contraceptive pills. This could be attributed to high production of reactive oxygen species in the rats administered combined oral contraceptive pills. This demonstrates that combined oral contraceptive pills induce oxidative stress. This is in agreement with De Groote et al.<sup><xref ref-type="bibr" rid="B39">39</xref></sup> and Massart et al.<sup><xref ref-type="bibr" rid="B40">40</xref></sup></p>
      <p>Garlic has been used to treat and prevent hyperlipidemia, atherosclerosis, arrhythmia diabetic thrombosis, hypertension, and other cardiovascular and metabolic illnesses.<sup><xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B41">41</xref></sup> Data from the current study showed that the post-treatment of the rats with aqueous garlic extract caused a significant drastic reduction in the serum levels of troponin-1, lactate dehydrogenase, and creatine kinase-MB following treatment with 500 mg/kg and 700 mg/kg body weight of <italic>Allium sativum</italic> extract (groups D and E). The study has shown that the treatment of the ischemia induced by oral contraceptive pills with garlic juice significantly protected the heart and myocardial function. The decrease in serum troponin-1, lactate dehydrogenase, and creatine kinase MB is mainly attributed to the bioactive metabolite allicin found in crushed garlic and its breakdown into organic polysulfides, which interact with thiol-containing compounds (glutathione) found in biological systems to produce free H<sub>2</sub>S, preventing myocardial injury and dysfunction.<sup><xref ref-type="bibr" rid="B20">20</xref></sup></p>
      <p>The malondialdehyde levels also showed a drastic reduction in the rats treated with garlic extract (groups D and E) compared with group B. This reduction shows that garlic may be able to protect cell membranes from free radical damage and stop the leaking of cardiac biomarkers, in addition to preventing LDL oxidative modification and maintaining a healthy lipid profile.<sup><xref ref-type="bibr" rid="B42">42</xref></sup> In addition, allicin present in garlic can inhibit free radical production and scavenge the chain-carrying peroxyl radicals of the substrates by transferring its allylic hydrogen to the oxidized substrate.<sup><xref ref-type="bibr" rid="B43">43</xref></sup> Garlic also has phytochemicals, including S-allylcysteine, sulfur metabolites, and S-allylmercaptocysteine, which have strong antioxidant effects.<sup><xref ref-type="bibr" rid="B44">44</xref></sup></p>
      <p>Results from the present study suggest that garlic has the potential ability to reverse ischemic heart disease caused by oral contraceptive pills. This is in agreement with previous reports by Madaj and Budoff,<sup><xref ref-type="bibr" rid="B45">45</xref></sup> who reported that garlic possesses beneficial effects and could thus be used as a therapeutic agent for many illnesses, including cardiovascular diseases. Several studies have demonstrated that the bioactive compound allicin is responsible for most biological activities of garlic.<sup><xref ref-type="bibr" rid="B46">46</xref></sup> The enzyme alliinase and alliin are present in an uncrushed garlic cell. Once the garlic clove is crushed, alliin and alliinase are released to form allicin, which is the primary bioactive compound found in garlic juice.<sup><xref ref-type="bibr" rid="B18">18</xref></sup> Thus, it is on this ground that allicin is probably responsible for cardioprotective/ameliorative effect of garlic juice on ischemic heart disease induced by oral contraceptives in female rats. Previous studies have reported that treatment with allicin-containing garlic significantly protected the rat heart against monocrotaline-induced coronary endothelial dysfunction and prevented the development of right ventricular hypertrophy.<sup><xref ref-type="bibr" rid="B46">46</xref></sup> Studies by S&#225;nchez-Gloria et al.<sup><xref ref-type="bibr" rid="B47">47</xref></sup> and Deng et al.<sup><xref ref-type="bibr" rid="B48">48</xref></sup> also demonstrated that allicin improves post-ischemic pulmonary artery flow. Allicin has also been reported to be responsible for the mediation of the protective effect of garlic via its action on coronary endothelial function and vasoreactivity. Therefore, in agreement with reports from other studies, the cardioprotective/ameliorative potential of the aqueous garlic extract in the current study is probably mediated via the vasoregulatory effects of garlic extract and its antioxidant activity in ischemia induced by combined oral contraceptive pills.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusion</title>
      <p>The results of this study have demonstrated that the treatment of rats with <italic>Allium sativum</italic> juice reverses ischemic heart disease induced by combined oral contraceptives, lessens cytoarchitectural changes in the heart, and ameliorates cardiac dysfunction. The biochemical and histomorphology alterations in the heart, as observed by biochemical parameters and histological photomicrographs, all revealed cardioprotective potential of the garlic juice.</p>
      <p>
        <fig id="f06">
          <label>Figure 5</label>
          <caption>
            <title>&#8211; Photomicrograph of transverse section of an adult rat administered with 0.6 mg/kg body weight of combined oral contraceptive pills orally for 48 days and post-treated with 700 mg/kg body weight of aqueous garlic extract for 48 days after administration of oral contraceptive pills. The section shows normal histomorphology of the heart tissue. Conclusion: The substance administered is non-toxic and shows potential ability to reverse the ischemic changes observed in group B.</title>
          </caption>
          <graphic xlink:href="2359-5647-ijcs-37-e20230060-30060-gf05.tif"/></fig>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>The authors acknowledge the support of the staff of the Department of Medical Laboratory Science and the Department of Pharmacology at Niger Delta University. We equally appreciate the laboratory instructors and final year students of the Department of Medical Laboratory Science for their immense support.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1</label>
        <mixed-citation>1. Jin J. JAMA Patient Page. Oral Contraceptives. JAMA. 2014;311(3):321. doi: 10.1001/jama.2013.283505.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jin</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>JAMA Patient Page. Oral Contraceptives</article-title>
          <source>JAMA</source>
          <year>2014</year>
          <volume>311</volume>
          <issue>3</issue>
          <size units="pages">321</size>
          <pub-id pub-id-type="doi">10.1001/jama.2013.283505</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation>2. Park H, Kim K. Trends and Factors Associated with Oral Contraceptive Use among Korean Women. Healthcare. 2021;9(10):1386. doi: 10.3390/healthcare9101386.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Trends and Factors Associated with Oral Contraceptive Use among Korean Women</article-title>
          <source>Healthcare</source>
          <year>2021</year>
          <volume>9</volume>
          <issue>10</issue>
          <size units="pages">1386</size>
          <pub-id pub-id-type="doi">10.3390/healthcare9101386</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation>3. Akshara S, Rohitash J. Adverse Effect of Combined Oral Contraceptive Pills. Asian J Pharm Clin Res. 2017;10(1):17-21. doi:10.22159/ajpcr.2017.v10i1.14565.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akshara</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rohitash</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Adverse Effect of Combined Oral Contraceptive Pills</article-title>
          <source>Asian J Pharm Clin Res</source>
          <year>2017</year>
          <volume>10</volume>
          <issue>1</issue>
          <fpage>17</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.22159/ajpcr.2017.v10i1.14565</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation>4. Shulman LP. The State of Hormonal Contraception Today: Benefits and Risks of Hormonal Contraceptives: Combined Estrogen and Progestin Contraceptives. Am J Obstet Gynecol. 2011;205(4 Suppl):S9-13. doi: 10.1016/j.ajog.2011.06.057.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shulman</surname>
              <given-names>LP</given-names>
            </name>
          </person-group>
          <article-title>The State of Hormonal Contraception Today: Benefits and Risks of Hormonal Contraceptives: Combined Estrogen and Progestin Contraceptives</article-title>
          <source>Am J Obstet Gynecol</source>
          <year>2011</year>
          <volume>205</volume>
          <issue>4</issue>
          <supplement>Suppl</supplement>
          <fpage>S9</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajog.2011.06.057</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation>5. Allen RH, Cwiak CA, Kaunitz AM. Contraception in Women Over 40 Years of Age. CMAJ. 2013;185(7):565-73. doi: 10.1503/cmaj.121280.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Allen</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Cwiak</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Kaunitz</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Contraception in Women Over 40 Years of Age</article-title>
          <source>CMAJ</source>
          <year>2013</year>
          <volume>185</volume>
          <issue>7</issue>
          <fpage>565</fpage>
          <lpage>573</lpage>
          <pub-id pub-id-type="doi">10.1503/cmaj.121280</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation>6. Al-Juhaishi AMR, Al-Shehristani RMM, Al-Obaidi ZMJ. The Correlation of the Use of Oral Contraceptive Pills and the Risk of Ischemic Heart Disease in Perimenopausal Women. J Pharm Sci Res. 2018;10(6):1464-7.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Juhaishi</surname>
              <given-names>AMR</given-names>
            </name>
            <name>
              <surname>Al-Shehristani</surname>
              <given-names>RMM</given-names>
            </name>
            <name>
              <surname>Al-Obaidi</surname>
              <given-names>ZMJ</given-names>
            </name>
          </person-group>
          <article-title>The Correlation of the Use of Oral Contraceptive Pills and the Risk of Ischemic Heart Disease in Perimenopausal Women</article-title>
          <source>J Pharm Sci Res</source>
          <year>2018</year>
          <volume>10</volume>
          <issue>6</issue>
          <fpage>1464</fpage>
          <lpage>1467</lpage>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation>7. Naz F, Jyoti S, Akhtar N, Afzal M, Siddique YH. Lipid Profile of Women Using Oral Contraceptive Pills. Pak J Biol Sci. 2012;15(19):947-50. doi: 10.3923/pjbs.2012.947.950.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Naz</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Jyoti</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Akhtar</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Afzal</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Siddique</surname>
              <given-names>YH</given-names>
            </name>
          </person-group>
          <article-title>Lipid Profile of Women Using Oral Contraceptive Pills</article-title>
          <source>Pak J Biol Sci</source>
          <year>2012</year>
          <volume>15</volume>
          <issue>19</issue>
          <fpage>947</fpage>
          <lpage>950</lpage>
          <pub-id pub-id-type="doi">10.3923/pjbs.2012.947.950</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation>8. World Health Organization. Family Planning: A Global Handbook for Providers. Geneva: WHO; 2008.</mixed-citation>
        <element-citation publication-type="report">
          <person-group person-group-type="author">
            <collab>World Health Organization</collab>
          </person-group>
          <source>Family Planning: A Global Handbook for Providers</source>
          <publisher-loc>Geneva</publisher-loc>
          <publisher-name>WHO</publisher-name>
          <year>2008</year>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation>9. World Health Organization. Global Atlas on Cardiovascular Disease Prevention and Control. Geneva: WHO; 2011.</mixed-citation>
        <element-citation publication-type="report">
          <person-group person-group-type="author">
            <collab>World Health Organization</collab>
          </person-group>
          <source>Global Atlas on Cardiovascular Disease Prevention and Control</source>
          <publisher-loc>Geneva</publisher-loc>
          <publisher-name>WHO</publisher-name>
          <year>2011</year>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <mixed-citation>10. Andrew EM. Epidemiology and Global burden of Ischaemic Heart Disease. In: Camm AJ, Luscher TF, Maures G, Serruys PW. The ESC Textbook of Cardiovascular Medicine. London: Oxford University Press; 2018. p. 298-304.</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Andrew</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <chapter-title>Epidemiology and Global burden of Ischaemic Heart Disease</chapter-title>
          <person-group person-group-type="author">
            <name>
              <surname>Camm</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Luscher</surname>
              <given-names>TF</given-names>
            </name>
            <name>
              <surname>Maures</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Serruys</surname>
              <given-names>PW</given-names>
            </name>
          </person-group>
          <source>The ESC Textbook of Cardiovascular Medicine</source>
          <publisher-loc>London</publisher-loc>
          <publisher-name>Oxford University Press</publisher-name>
          <year>2018</year>
          <fpage>298</fpage>
          <lpage>304</lpage>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <mixed-citation>11. Khan MA, Hashim MJ, Mustafa H, Baniyas MY, Al Suwaidi SKBM, AlKatheeri R, et al. Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study. Cureus. 2020;12(7):e9349. doi: 10.7759/cureus.9349.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khan</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Hashim</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Mustafa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Baniyas</surname>
              <given-names>MY</given-names>
            </name>
            <name>
              <surname>Al Suwaidi</surname>
              <given-names>SKBM</given-names>
            </name>
            <name>
              <surname>AlKatheeri</surname>
              <given-names>R</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study</article-title>
          <source>Cureus</source>
          <year>2020</year>
          <volume>12</volume>
          <issue>7</issue>
          <elocation-id>e9349</elocation-id>
          <pub-id pub-id-type="doi">10.7759/cureus.9349</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <mixed-citation>12. &#216;ygarden H, Fromm A, Sand KM, Eide GE, Thomassen L, Naess H, et al. Can the Cardiovascular Family History Reported by Our Patients be Trusted? The Norwegian Stroke in the Young Study. Eur J Neurol. 2016;23(1):154-9. doi: 10.1111/ene.12824.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>&#216;ygarden</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fromm</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sand</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Eide</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Thomassen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Naess</surname>
              <given-names>H</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Can the Cardiovascular Family History Reported by Our Patients be Trusted? The Norwegian Stroke in the Young Study</article-title>
          <source>Eur J Neurol</source>
          <year>2016</year>
          <volume>23</volume>
          <issue>1</issue>
          <fpage>154</fpage>
          <lpage>159</lpage>
          <pub-id pub-id-type="doi">10.1111/ene.12824</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <mixed-citation>13. Tulloch H, Greenman PS, Tass&#233; V. Post-Traumatic Stress Disorder Among Cardiac Patients: Prevalence, Risk Factors, and Considerations for Assessment and Treatment. Behav Sci. 2014;5(1):27-40. doi: 10.3390/bs5010027.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tulloch</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Greenman</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Tass&#233;</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Post-Traumatic Stress Disorder Among Cardiac Patients: Prevalence, Risk Factors, and Considerations for Assessment and Treatment</article-title>
          <source>Behav Sci</source>
          <year>2014</year>
          <volume>5</volume>
          <issue>1</issue>
          <fpage>27</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="doi">10.3390/bs5010027</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <mixed-citation>14. Thun MJ, Carter BD, Feskanich D, Freedman ND, Prentice R, Lopez AD, et al. 50-Year Trends in Smoking-Related Mortality in the United States. N Engl J Med. 2013;368(4):351-64. doi: 10.1056/NEJMsa1211127.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thun</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Carter</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Feskanich</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Freedman</surname>
              <given-names>ND</given-names>
            </name>
            <name>
              <surname>Prentice</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lopez</surname>
              <given-names>AD</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>50-Year Trends in Smoking-Related Mortality in the United States</article-title>
          <source>N Engl J Med</source>
          <year>2013</year>
          <volume>368</volume>
          <issue>4</issue>
          <fpage>351</fpage>
          <lpage>364</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMsa1211127</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <mixed-citation>15. Dawber TR, Moore FE, Mann GV. II. Coronary Heart Disease in the Framingham Study. Int J Epidemiol. 2015;44(6):1767-80. doi: 10.1093/ije/dyv346.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dawber</surname>
              <given-names>TR</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>FE</given-names>
            </name>
            <name>
              <surname>Mann</surname>
              <given-names>GV. II</given-names>
            </name>
          </person-group>
          <article-title>Coronary Heart Disease in the Framingham Study</article-title>
          <source>Int J Epidemiol</source>
          <year>2015</year>
          <volume>44</volume>
          <issue>6</issue>
          <fpage>1767</fpage>
          <lpage>1780</lpage>
          <pub-id pub-id-type="doi">10.1093/ije/dyv346</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <mixed-citation>16. Antman EM, Selwyn AP, Braunwald E, Loscalzo J. Ischemia Heart Disease. In: Loscalzo, editor. Harrison`s Cardiovascular Medicine. New York: McGrow-Hill; 2010. p. 366-370.</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Antman</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Selwyn</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Braunwald</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Loscalzo</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <chapter-title>Ischemia Heart Disease</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Loscalzo</surname>
            </name>
          </person-group>
          <source>Harrison`s Cardiovascular Medicine</source>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>McGrow-Hill</publisher-name>
          <year>2010</year>
          <fpage>366</fpage>
          <lpage>370</lpage>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <mixed-citation>17. Pothineni NVK, Subramany S, Kuriakose K, Shirazi LF, Romeo F, Shah PK, et al. Infections, Atherosclerosis, and Coronary Heart Disease. Eur Heart J. 2017;38(43):3195-201. doi: 10.1093/eurheartj/ehx362.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pothineni</surname>
              <given-names>NVK</given-names>
            </name>
            <name>
              <surname>Subramany</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kuriakose</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Shirazi</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Romeo</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>PK</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Infections, Atherosclerosis, and Coronary Heart Disease</article-title>
          <source>Eur Heart J</source>
          <year>2017</year>
          <volume>38</volume>
          <issue>43</issue>
          <fpage>3195</fpage>
          <lpage>3201</lpage>
          <pub-id pub-id-type="doi">10.1093/eurheartj/ehx362</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <mixed-citation>18. Varshney R, Budoff MJ. Garlic and Heart Disease. J Nutr. 2016;146(2):416S-421S. doi: 10.3945/jn.114.202333.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Varshney</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Budoff</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Garlic and Heart Disease</article-title>
          <source>J Nutr</source>
          <year>2016</year>
          <volume>146</volume>
          <issue>2</issue>
          <fpage>416S</fpage>
          <lpage>421S</lpage>
          <pub-id pub-id-type="doi">10.3945/jn.114.202333</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <mixed-citation>19. El-Saber Batiha G, Magdy Beshbishy A, G Wasef L, Elewa YHA, A Al-Sagan A, Abd El-Hack ME, et al. Chemical Constituents and Pharmacological Activities of Garlic (Allium sativum L.): A Review. Nutrients. 2020;12(3):872. doi: 10.3390/nu12030872.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>El-Saber Batiha</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Magdy Beshbishy</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>G Wasef</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Elewa</surname>
              <given-names>YHA</given-names>
            </name>
            <name>
              <surname>A Al-Sagan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Abd El-Hack</surname>
              <given-names>ME</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Chemical Constituents and Pharmacological Activities of Garlic (Allium sativum L.): A Review</article-title>
          <source>Nutrients</source>
          <year>2020</year>
          <volume>12</volume>
          <issue>3</issue>
          <size units="pages">872</size>
          <pub-id pub-id-type="doi">10.3390/nu12030872</pub-id>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <mixed-citation>20. Bradley JM, Organ CL, Lefer DJ. Garlic-Derived Organic Polysulfides and Myocardial Protection. J Nutr. 2016;146(2):403S-409S. doi: 10.3945/jn.114.208066.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bradley</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Organ</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Lefer</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>Garlic-Derived Organic Polysulfides and Myocardial Protection</article-title>
          <source>J Nutr</source>
          <year>2016</year>
          <volume>146</volume>
          <issue>2</issue>
          <fpage>403S</fpage>
          <lpage>409S</lpage>
          <pub-id pub-id-type="doi">10.3945/jn.114.208066</pub-id>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <mixed-citation>21. Hussein JH, Mohammed YH, Imad HH. A Review: Anti-microbial, Anti-inflammatory Effect and Cardiovascular effects of Garlic: Allium sativum. Research J Pharm Tech. 2017;10(11):4069-78. doi: 10.5958/0974-360X.2017.00738.7.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hussein</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Mohammed</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Imad</surname>
              <given-names>HH</given-names>
            </name>
          </person-group>
          <article-title>A Review: Anti-microbial, Anti-inflammatory Effect and Cardiovascular effects of Garlic: Allium sativum</article-title>
          <source>Research J Pharm Tech</source>
          <year>2017</year>
          <volume>10</volume>
          <issue>11</issue>
          <fpage>4069</fpage>
          <lpage>4078</lpage>
          <pub-id pub-id-type="doi">10.5958/0974-360X.2017.00738.7</pub-id>
        </element-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <mixed-citation>22. Institute of Laboratory Animal Resources. Guide for the Care and Use of Laboratory Animals. Washington, DC: The National Academies Press; 1996.</mixed-citation>
        <element-citation publication-type="report">
          <person-group person-group-type="author">
            <collab>Institute of Laboratory Animal Resources</collab>
          </person-group>
          <source>Guide for the Care and Use of Laboratory Animals</source>
          <publisher-loc>Washington, DC</publisher-loc>
          <publisher-name>The National Academies Press</publisher-name>
          <year>1996</year>
        </element-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <mixed-citation>23. Toryila JE, Amadi K, Odeh SO, Adelaiye AB, Egesie UG, Achie N. Dynamics of Combined Oral Contraceptive: A Study of Some Haematological Parameters in Female Wistar Rats. OSR J Pharm. 2014;4(9):15-9. doi:10.9790/3013-0409015019.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Toryila</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Amadi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Odeh</surname>
              <given-names>SO</given-names>
            </name>
            <name>
              <surname>Adelaiye</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Egesie</surname>
              <given-names>UG</given-names>
            </name>
            <name>
              <surname>Achie</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Dynamics of Combined Oral Contraceptive: A Study of Some Haematological Parameters in Female Wistar Rats</article-title>
          <source>OSR J Pharm</source>
          <year>2014</year>
          <volume>4</volume>
          <issue>9</issue>
          <fpage>15</fpage>
          <lpage>19</lpage>
          <pub-id pub-id-type="doi">10.9790/3013-0409015019</pub-id>
        </element-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <mixed-citation>24. Ghiasi, JG. Garlic (Allium sativum) Juice Protects from Semen Oxidative Stress in Male Rats Exposed to Chromium Chloride. Anim Reprod. 2014;11(4):526-32.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ghiasi</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
          <article-title>Garlic (Allium sativum) Juice Protects from Semen Oxidative Stress in Male Rats Exposed to Chromium Chloride</article-title>
          <source>Anim Reprod</source>
          <year>2014</year>
          <volume>11</volume>
          <issue>4</issue>
          <fpage>526</fpage>
          <lpage>532</lpage>
        </element-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <mixed-citation>25. Deora PS, Mishra CK, Mavani P, Asha R, Shrivastava B, Rajesh KN. Effective Alternative Methods of LD50 Help to Save Number of Experimental Animals. J Chem Pharm Res. 2010;2(6):450-453.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deora</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Mishra</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Mavani</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Asha</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Shrivastava</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Rajesh</surname>
              <given-names>KN</given-names>
            </name>
          </person-group>
          <article-title>Effective Alternative Methods of LD50 Help to Save Number of Experimental Animals</article-title>
          <source>J Chem Pharm Res</source>
          <year>2010</year>
          <volume>2</volume>
          <issue>6</issue>
          <fpage>450</fpage>
          <lpage>453</lpage>
        </element-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <mixed-citation>26. Young DS. Effects on Clinical Laboratory Tests. In: Donald S, Young MD, editors. Drugs Disease, Herbs &amp; Natural Products. New York: John Wiley &amp; Sons; 2021.</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Young</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
          <chapter-title>Effects on Clinical Laboratory Tests</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Donald</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>MD</given-names>
            </name>
            <role>editors</role>
          </person-group>
          <source>Drugs Disease, Herbs &amp; Natural Products</source>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>John Wiley &amp; Sons</publisher-name>
          <year>2021</year>
        </element-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <mixed-citation>27. Cervellin G, Comelli I, Lippi G. Rhabdomyolysis: Historical Background, Clinical, Diagnostic and Therapeutic Features. Clin Chem Lab Med. 2010;48(6):749-56. doi: 10.1515/CCLM.2010.151.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cervellin</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Comelli</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Lippi</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Rhabdomyolysis: Historical Background, Clinical, Diagnostic and Therapeutic Features</article-title>
          <source>Clin Chem Lab Med</source>
          <year>2010</year>
          <volume>48</volume>
          <issue>6</issue>
          <fpage>749</fpage>
          <lpage>756</lpage>
          <pub-id pub-id-type="doi">10.1515/CCLM.2010.151</pub-id>
        </element-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <mixed-citation>28. Babuin L, Jaffe AS. Troponin: The Biomarker of Choice for the Detection of Cardiac Injury. CMAJ. 2005;173(10):1191-202. doi: 10.1503/cmaj/051291.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Babuin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Jaffe</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Troponin: The Biomarker of Choice for the Detection of Cardiac Injury</article-title>
          <source>CMAJ</source>
          <year>2005</year>
          <volume>173</volume>
          <issue>10</issue>
          <fpage>1191</fpage>
          <lpage>1202</lpage>
          <pub-id pub-id-type="doi">10.1503/cmaj/051291</pub-id>
        </element-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <mixed-citation>29. Ochei JK, Kolhatkar A. Medical Laboratory Science Theory and Practice. London McGraw Hill Education; 2005.</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Ochei</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Kolhatkar</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <source>Medical Laboratory Science Theory and Practice</source>
          <publisher-loc>London McGraw Hill Education</publisher-loc>
          <year>2005</year>
        </element-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <mixed-citation>30. Satoskar RS, Bhandarkar SD, Ainapure SS. Pharmacology and m Pharmacotherapeutics. 24th ed. Mumbai: Popular Prakashan; 2015.</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Satoskar</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Bhandarkar</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Ainapure</surname>
              <given-names>SS</given-names>
            </name>
          </person-group>
          <source>Pharmacology and m Pharmacotherapeutics</source>
          <edition>24th</edition>
          <publisher-loc>Mumbai</publisher-loc>
          <publisher-name>Popular Prakashan</publisher-name>
          <year>2015</year>
        </element-citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <mixed-citation>31. Roach RE, Helmerhorst FM, Lijfering WM, Stijnen T, Algra A, Dekkers OM. Combined Oral Contraceptives: The Risk of Myocardial Infarction and Ischemic Stroke. Cochrane Database Syst Rev. 2015;2015(8):CD011054. doi: 10.1002/14651858.CD011054.pub2.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roach</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Helmerhorst</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Lijfering</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Stijnen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Algra</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dekkers</surname>
              <given-names>OM</given-names>
            </name>
          </person-group>
          <article-title>Combined Oral Contraceptives: The Risk of Myocardial Infarction and Ischemic Stroke</article-title>
          <source>Cochrane Database Syst Rev</source>
          <year>2015</year>
          <volume>2015</volume>
          <issue>8</issue>
          <size units="pages">CD011054</size>
          <pub-id pub-id-type="doi">10.1002/14651858.CD011054.pub2</pub-id>
        </element-citation>
      </ref>
      <ref id="B32">
        <label>32</label>
        <mixed-citation>32. Wang XY, Zhang F, Zhang C, Zheng LR, Yang J. The Biomarkers for Acute Myocardial Infarction and Heart Failure. Biomed Res Int. 2020;2020:2018035. doi: 10.1155/2020/2018035.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>XY</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>The Biomarkers for Acute Myocardial Infarction and Heart Failure</article-title>
          <source>Biomed Res Int</source>
          <year>2020</year>
          <volume>2020</volume>
          <size units="pages">2018035</size>
          <pub-id pub-id-type="doi">10.1155/2020/2018035</pub-id>
        </element-citation>
      </ref>
      <ref id="B33">
        <label>33</label>
        <mixed-citation>33. Zakharova MY, Meyer RM, Brandy KR, Datta YH, Joseph MS, Schreiner PJ, et al. Risk Factors for Heart Attack, Stroke, and Venous Thrombosis Associated with Hormonal Contraceptive Use. Clin Appl Thromb Hemost. 2011;17(4):323-31. doi: 10.1177/1076029610368670.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zakharova</surname>
              <given-names>MY</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Brandy</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Datta</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Joseph</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Schreiner</surname>
              <given-names>PJ</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Risk Factors for Heart Attack, Stroke, and Venous Thrombosis Associated with Hormonal Contraceptive Use</article-title>
          <source>Clin Appl Thromb Hemost</source>
          <year>2011</year>
          <volume>17</volume>
          <issue>4</issue>
          <fpage>323</fpage>
          <lpage>331</lpage>
          <pub-id pub-id-type="doi">10.1177/1076029610368670</pub-id>
        </element-citation>
      </ref>
      <ref id="B34">
        <label>34</label>
        <mixed-citation>34. Tchaikovski SN, Rosing J. Mechanisms of Estrogen-Induced Venous Thromboembolism. Thromb Res. 2010;126(1):5-11. doi: 10.1016/j.thromres.2010.01.045.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tchaikovski</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Rosing</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms of Estrogen-Induced Venous Thromboembolism</article-title>
          <source>Thromb Res</source>
          <year>2010</year>
          <volume>126</volume>
          <issue>1</issue>
          <fpage>5</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="doi">10.1016/j.thromres.2010.01.045</pub-id>
        </element-citation>
      </ref>
      <ref id="B35">
        <label>35</label>
        <mixed-citation>35. Borissoff JI, Spronk HM, ten Cate H. The Hemostatic System as a Modulator of Atherosclerosis. N Engl J Med. 2011;364(18):1746-60. doi: 10.1056/NEJMra1011670.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borissoff</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Spronk</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>ten Cate</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>The Hemostatic System as a Modulator of Atherosclerosis</article-title>
          <source>N Engl J Med</source>
          <year>2011</year>
          <volume>364</volume>
          <issue>18</issue>
          <fpage>1746</fpage>
          <lpage>1760</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMra1011670</pub-id>
        </element-citation>
      </ref>
      <ref id="B36">
        <label>36</label>
        <mixed-citation>36. Mallick AK, Ahsan M, Das B, Saxena S, Samanta S, Kukreja S. Study of Lipid Profile During Late Reproductive Phase, Perimenopause and Postmenopause in North Indian Women. Int J Med Res Rev. 2015;3(1):46-50. doi.org/10.17511/ijmrr.2015.i1.08.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mallick</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Ahsan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Das</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Saxena</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Samanta</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kukreja</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Study of Lipid Profile During Late Reproductive Phase, Perimenopause and Postmenopause in North Indian Women</article-title>
          <source>Int J Med Res Rev</source>
          <year>2015</year>
          <volume>3</volume>
          <issue>1</issue>
          <fpage>46</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="doi">10.17511/ijmrr.2015.i1.08</pub-id>
        </element-citation>
      </ref>
      <ref id="B37">
        <label>37</label>
        <mixed-citation>37. Pincemail J, Vanbelle S, Gaspard U, Collette G, Haleng J, Cheramy-Bien JP, et al. Effect of Different Contraceptive Methods on the Oxidative Stress Status in Women Aged 40 48 Years from the ELAN Study in the Province of Liege, Belgium. Hum Reprod. 2007;22(8):2335-43. doi: 10.1093/humrep/dem146.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pincemail</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Vanbelle</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gaspard</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Collette</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Haleng</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cheramy-Bien</surname>
              <given-names>JP</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Effect of Different Contraceptive Methods on the Oxidative Stress Status in Women Aged 40 48 Years from the ELAN Study in the Province of Liege, Belgium</article-title>
          <source>Hum Reprod</source>
          <year>2007</year>
          <volume>22</volume>
          <issue>8</issue>
          <fpage>2335</fpage>
          <lpage>2343</lpage>
          <pub-id pub-id-type="doi">10.1093/humrep/dem146</pub-id>
        </element-citation>
      </ref>
      <ref id="B38">
        <label>38</label>
        <mixed-citation>38. Al-Kushi AG, El-Boshy ME, ElSawy NA, Omar OAS, Header EA. Pathological Comparative Studies on Aqueous and Ethanolic Extracts of Zingiber Officinale on Antioxidants and Hypolipidemic Effects in Rats. Life Sci J. 2013;10(2):2393-403.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Kushi</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>El-Boshy</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>ElSawy</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Omar</surname>
              <given-names>OAS</given-names>
            </name>
            <name>
              <surname>Header</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title>Pathological Comparative Studies on Aqueous and Ethanolic Extracts of Zingiber Officinale on Antioxidants and Hypolipidemic Effects in Rats</article-title>
          <source>Life Sci J</source>
          <year>2013</year>
          <volume>10</volume>
          <issue>2</issue>
          <fpage>2393</fpage>
          <lpage>2403</lpage>
        </element-citation>
      </ref>
      <ref id="B39">
        <label>39</label>
        <mixed-citation>39. De Groote D, d'Hauterive SP, Pintiaux A, Balteau B, Gerday C, Claesen J, et al. Effects of Oral Contraception with Ethinylestradiol and Drospirenone on Oxidative Stress in Women 18-35 Years Old. Contraception. 2009;80(2):187-93. doi: 10.1016/j.contraception.2009.02.015.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Groote</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>d'Hauterive</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Pintiaux</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Balteau</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Gerday</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Claesen</surname>
              <given-names>J</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Effects of Oral Contraception with Ethinylestradiol and Drospirenone on Oxidative Stress in Women 18-35 Years Old</article-title>
          <source>Contraception</source>
          <year>2009</year>
          <volume>80</volume>
          <issue>2</issue>
          <fpage>187</fpage>
          <lpage>193</lpage>
          <pub-id pub-id-type="doi">10.1016/j.contraception.2009.02.015</pub-id>
        </element-citation>
      </ref>
      <ref id="B40">
        <label>40</label>
        <mixed-citation>40. Massart A, Portier H, Rosado F, Toumi H, Filaire E. Lipid Peroxidation in Judoists Using Oral Contraceptives. Int J Sports Med. 2012;33(10):781-8. doi: 10.1055/s-0032-1306282.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Massart</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Portier</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Rosado</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Toumi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Filaire</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Lipid Peroxidation in Judoists Using Oral Contraceptives</article-title>
          <source>Int J Sports Med</source>
          <year>2012</year>
          <volume>33</volume>
          <issue>10</issue>
          <fpage>781</fpage>
          <lpage>788</lpage>
          <pub-id pub-id-type="doi">10.1055/s-0032-1306282</pub-id>
        </element-citation>
      </ref>
      <ref id="B41">
        <label>41</label>
        <mixed-citation>41. Khan SH, Hassan S, Sarder R, Anjum MA. Effects of Dietary Garlic Powder on Cholesterol Concentration in Native Desi Laying Hens. Am J Food Technol. 2008;3(3): 207-13.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khan</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Hassan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sarder</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Anjum</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Effects of Dietary Garlic Powder on Cholesterol Concentration in Native Desi Laying Hens</article-title>
          <source>Am J Food Technol</source>
          <year>2008</year>
          <volume>3</volume>
          <issue>3</issue>
          <fpage>207</fpage>
          <lpage>213</lpage>
        </element-citation>
      </ref>
      <ref id="B42">
        <label>42</label>
        <mixed-citation>42. Abdel-Baky ES, Abdel-Rahman ON. Cardioprotective Effects of the Garlic (Allium sativum) in Sodium Fluoride-Treated Rats. JoBAZ 2020;81:7. doi: 10.1186/s41936-020-0140-0.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abdel-Baky</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Abdel-Rahman</surname>
              <given-names>ON</given-names>
            </name>
          </person-group>
          <article-title>Cardioprotective Effects of the Garlic (Allium sativum) in Sodium Fluoride-Treated Rats</article-title>
          <source>JoBAZ</source>
          <year>2020</year>
          <volume>81</volume>
          <size units="pages">7</size>
          <pub-id pub-id-type="doi">10.1186/s41936-020-0140-0</pub-id>
        </element-citation>
      </ref>
      <ref id="B43">
        <label>43</label>
        <mixed-citation>43. Miron T, Wilchek M, Sharp A, Nakagawa Y, Naoi M, Nozawa Y, et al. Allicin Inhibits Cell Growth and Induces Apoptosis Through the Mitochondrial Pathway in HL60 and U937 cells. J Nutr Biochem. 2008;19(8):524-35. doi: 10.1016/j.jnutbio.2007.06.009.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miron</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wilchek</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sharp</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nakagawa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Naoi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nozawa</surname>
              <given-names>Y</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Allicin Inhibits Cell Growth and Induces Apoptosis Through the Mitochondrial Pathway in HL60 and U937 cells</article-title>
          <source>J Nutr Biochem</source>
          <year>2008</year>
          <volume>19</volume>
          <issue>8</issue>
          <fpage>524</fpage>
          <lpage>535</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jnutbio.2007.06.009</pub-id>
        </element-citation>
      </ref>
      <ref id="B44">
        <label>44</label>
        <mixed-citation>44. Asdaq SM, Inamdar MN, Asad M. Pharmacodynamic Interaction of Garlic with Propranolol in Ischemia-Reperfusion Induced Myocardial Damage. Pak J Pharm Sci. 2010;23(1):42-7.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Asdaq</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Inamdar</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Asad</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Pharmacodynamic Interaction of Garlic with Propranolol in Ischemia-Reperfusion Induced Myocardial Damage</article-title>
          <source>Pak J Pharm Sci</source>
          <year>2010</year>
          <volume>23</volume>
          <issue>1</issue>
          <fpage>42</fpage>
          <lpage>47</lpage>
        </element-citation>
      </ref>
      <ref id="B45">
        <label>45</label>
        <mixed-citation>45. Madaj PM, Budoff M. JA Review: Garlic Effects on the Cardiovascular System. J Cardiol &amp; Cardiovasc Ther. 2017;5(2):555658. doi: 10.19080/JOCCT.2017.05.555658.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Madaj</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Budoff</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>JA Review: Garlic Effects on the Cardiovascular System</article-title>
          <source>J Cardiol &amp; Cardiovasc Ther</source>
          <year>2017</year>
          <volume>5</volume>
          <issue>2</issue>
          <size units="pages">555658</size>
          <pub-id pub-id-type="doi">10.19080/JOCCT.2017.05.555658</pub-id>
        </element-citation>
      </ref>
      <ref id="B46">
        <label>46</label>
        <mixed-citation>46. Shackebaei D, Ghazvineh S, Godini A, Pilehvarian A, Reshadat S. Cardioprotective Effect of Garlic Juice on the Isolated Rat Heart in Ischemia- Reperfusion. J Med Plant Res. 2010; 9(35): 71-9.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shackebaei</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ghazvineh</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Godini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pilehvarian</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Reshadat</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Cardioprotective Effect of Garlic Juice on the Isolated Rat Heart in Ischemia- Reperfusion</article-title>
          <source>J Med Plant Res</source>
          <year>2010</year>
          <volume>9</volume>
          <issue>35</issue>
          <fpage>71</fpage>
          <lpage>79</lpage>
        </element-citation>
      </ref>
      <ref id="B47">
        <label>47</label>
        <mixed-citation>47. S&#225;nchez-Gloria JL, Arellano-Buend&#237;a AS, Ju&#225;rez-Rojas JG, Garc&#237;a-Arroyo FE, Arg&#252;ello-Garc&#237;a R, S&#225;nchez-Mu&#241;oz F, et al. Cellular Mechanisms Underlying the Cardioprotective Role of Allicin on Cardiovascular Diseases. Int J Mol Sci. 2022;23(16):9082. doi: 10.3390/ijms23169082.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S&#225;nchez-Gloria</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Arellano-Buend&#237;a</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Ju&#225;rez-Rojas</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Garc&#237;a-Arroyo</surname>
              <given-names>FE</given-names>
            </name>
            <name>
              <surname>Arg&#252;ello-Garc&#237;a</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>S&#225;nchez-Mu&#241;oz</surname>
              <given-names>F</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Cellular Mechanisms Underlying the Cardioprotective Role of Allicin on Cardiovascular Diseases</article-title>
          <source>Int J Mol Sci</source>
          <year>2022</year>
          <volume>23</volume>
          <issue>16</issue>
          <fpage>9082</fpage>
          <pub-id pub-id-type="doi">10.3390/ijms23169082</pub-id>
        </element-citation>
      </ref>
      <ref id="B48">
        <label>48</label>
        <mixed-citation>48. Deng X, Yang P, Gao T, Liu M, Li X. Allicin Attenuates Myocardial Apoptosis, Inflammation and Mitochondrial Injury During Hypoxia-Reoxygenation: An in Vitro Study. BMC Cardiovasc Disord. 2021;21(1):200. doi: 10.1186/s12872-021-01918-6.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deng</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Allicin Attenuates Myocardial Apoptosis, Inflammation and Mitochondrial Injury During Hypoxia-Reoxygenation: An in Vitro Study</article-title>
          <source>BMC Cardiovasc Disord</source>
          <year>2021</year>
          <volume>21</volume>
          <issue>1</issue>
          <size units="pages">200</size>
          <pub-id pub-id-type="doi">10.1186/s12872-021-01918-6</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn fn-type="other">
        <p>Study Association</p>
        <p>This article is part of the thesis of master submitted by Onitsha Enebrayi Nelson, from Department of Medical Laboratory Science Niger Delta University Nigeria.</p>
      </fn>
      <fn fn-type="other">
        <p>Ethics Approval and Consent to Participate</p>
        <p>This study was approved by the Ethics Committee on Animal Experiments of the College of Health Sciences Etich Committee, Niger Delta University, under the protocol number NDU/CHSEC/0392.</p>
      </fn>
    </fn-group>
    <fn-group>
      <fn fn-type="supported-by">
        <p>Sources of Funding</p>
        <p>There were no external funding sources for this study.</p>
      </fn>
    </fn-group>
  </back>
</article>
